Regulation of polymorphonuclear leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-activated protein kinase - PubMed (original) (raw)
. 2000 Apr 1;95(7):2407-12.
Affiliations
- PMID: 10733514
Free article
Regulation of polymorphonuclear leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-activated protein kinase
P J Mansfield et al. Blood. 2000.
Free article
Abstract
Polymorphonuclear leukocyte (PMNL) phagocytosis mediated by FcgammaRII proceeds in concert with activation of the mitogen-activated protein (MAP) kinase, extracellular signal-regulated kinase ERK2. We hypothesized that myosin light chain kinase (MLCK) could be phosphorylated and activated by ERK, thereby linking the MAP kinase pathway to the activation of cytoskeletal components required for pseudopod formation. To explore this potential linkage, PMNLs were challenged with antibody-coated erythrocytes (EIgG). Peak MLCK activity, 3-fold increased over controls, occurred at 4 to 6 minutes, corresponding with the peak rate of target ingestion and ERK2 activity. The MLCK inhibitor ML-7 (10 micromol/L) inhibited both phagocytosis and MLCK activity to basal values, thereby providing further support for the linkage between the functional response and the requirement for MLCK activation. The MAPK kinase (MEK) inhibitor PD098059 inhibited phagocytosis, MLCK activity, and ERK2 activity by 80% to 90%. To directly link ERK activation to MLCK activation, ERK2 was immunoprecipitated from PMNLs after EIgG ingestion. The isolated ERK2 was incubated with PMNL cytosol as a source of unactivated MLCK and with MLCK substrate; under these conditions ERK2 activated MLCK, resulting in phosphorylation of the MLCK substrate or of the myosin light chain itself. Because MLCK activates myosin, we evaluated the effect of directly inhibiting myosin adenosine triphosphatase using 2,3-butanedione monoxime (BDM) and found that phagocytosis was inhibited by more than 90% but MLCK activity remained unaffected. These results are consistent with the interpretation that MEK activates ERK, ERK2 then activates MLCK, and MLCK activates myosin. MLCK activation is a critical step in the cytoskeletal changes resulting in pseudopod formation.
Similar articles
- Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide.
Suchard SJ, Mansfield PJ, Boxer LA, Shayman JA. Suchard SJ, et al. J Immunol. 1997 May 15;158(10):4961-7. J Immunol. 1997. PMID: 9144515 - Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis.
Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Shayman JA, Boxer LA. Raeder EM, et al. J Immunol. 1999 Dec 15;163(12):6785-93. J Immunol. 1999. PMID: 10586078 - Sphingosine blocks human polymorphonuclear leukocyte phagocytosis through inhibition of mitogen-activated protein kinase activation.
Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Kjeldsen L, Shayman JA, Boxer LA. Raeder EM, et al. Blood. 1999 Jan 15;93(2):686-93. Blood. 1999. PMID: 9885231 - Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL. Nguyen DH, et al. J Cell Biol. 1999 Jul 12;146(1):149-64. doi: 10.1083/jcb.146.1.149. J Cell Biol. 1999. PMID: 10402467 Free PMC article. - Myosin light chain kinase signaling in endothelial barrier dysfunction.
Rigor RR, Shen Q, Pivetti CD, Wu MH, Yuan SY. Rigor RR, et al. Med Res Rev. 2013 Sep;33(5):911-33. doi: 10.1002/med.21270. Epub 2012 Aug 9. Med Res Rev. 2013. PMID: 22886693 Free PMC article. Review.
Cited by
- Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations.
Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C, Baffet G. Rescan C, et al. Mol Biol Cell. 2001 Mar;12(3):725-38. doi: 10.1091/mbc.12.3.725. Mol Biol Cell. 2001. PMID: 11251083 Free PMC article. - Loss of regulator of G protein signaling 5 promotes airway hyperresponsiveness in the absence of allergic inflammation.
Balenga NA, Jester W, Jiang M, Panettieri RA Jr, Druey KM. Balenga NA, et al. J Allergy Clin Immunol. 2014 Aug;134(2):451-9. doi: 10.1016/j.jaci.2014.01.019. Epub 2014 Mar 22. J Allergy Clin Immunol. 2014. PMID: 24666695 Free PMC article. - The involvement of MiR-1-clathrin pathway in the regulation of phagocytosis.
Liu C, Wang J, Zhang X. Liu C, et al. PLoS One. 2014 Jun 16;9(6):e98747. doi: 10.1371/journal.pone.0098747. eCollection 2014. PLoS One. 2014. PMID: 24932654 Free PMC article. - Myosin light chain kinase facilitates endocytosis of synaptic vesicles at hippocampal boutons.
Li L, Wu X, Yue HY, Zhu YC, Xu J. Li L, et al. J Neurochem. 2016 Jul;138(1):60-73. doi: 10.1111/jnc.13635. Epub 2016 May 16. J Neurochem. 2016. PMID: 27062289 Free PMC article. - The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.
Guégan JP, Frémin C, Baffet G. Guégan JP, et al. Int J Hepatol. 2012;2012:328372. doi: 10.1155/2012/328372. Epub 2012 Oct 24. Int J Hepatol. 2012. PMID: 23133759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous